Showing posts with label research. Show all posts
Showing posts with label research. Show all posts

Sunday, April 06, 2014

New Fields of Research Defined by Open Science Visionaries

The purpose of an open-science non-profit research startup like DIYgenomics is research innovation.

The value is in being able to propose a unique and visionary research agenda of questions that are forward-looking and not the focus or interest of the institutional research industry.

Research innovation falls into two tiers:

First is preventive medicine questions, ‘medicine that matters to me’ (e.g.; small groups or individuals), and non-pathologies.

More importantly, the second tier is defining completely new fields of research such as athletic performance genomics, social intelligence genomics, cognitive performance genomics, and DIYneuroscience, and making progress on widespread philosophical and societal problems such as the destigmatization of physical and mental health issues, and the reduction of discrimination as a broad social problem.

DIY open-science, crowdsourced health social networks, and community biohacking labs are the early-stage startup/venture capital arm of the expanding preventive medicine ecosystem of health services, and are able to surface projects of interest that can then be pursued at the institutional level as relevant.

Sunday, July 08, 2012

Memory and empathy studies launch on crowdsourced health platform!

Two new health studies organized by DIYgenomics and collaborators have recently launched on the crowdsourcing platform Genomera. One is a memory study: Dopamine Genes and Rapid Reality Adaptation in Thinking and the other is an empathy study: Social Intelligence Genomics & Empathy-Building.

The Genomera platform boasts over 700 community members who are interested in participating in studies. While several of the approximately 30 listed studies investigate genetics as a related component of health, it is not necessary to have data from 23andMe or other consumer genomics services to join the health collaboration community and participate in studies. There are already 40 participants in the memory study and almost 20 in the empathy study.

The objective of the memory study is to see if genetic variants related to dopamine processing in the brain impact the processing of memories. The study is being conducted in conjunction with leading researchers at the Center of Cognitive Neurorehabilitation in Geneva Switzerland. The participation requirements are to complete an online Memory Filtering Task which takes approximately 40 minutes and a short Demographic Survey.

The objective of the empathy study is to confirm and extend research linking genetic profile and social intelligence, specifically whether individuals with certain genetic profiles may have a greater natural capacity for optimism and empathy, extraversion, and altruism. The participation requirement is to complete two short standardized online surveys for empathy quotient and other personality attributes. In addition, there is an optionally available Personal Virtual Coach app for empathy-building, a sort of SIRI 2.0 for mental performance optimization.

Sunday, July 25, 2010

Citizen scientists innovate research model

It is clear that quantified self-tracking, preventive medicine, and community-based research conducted by citizen scientists could be a huge new industry. The coming era of very large data sets and continuously collected information with algorithmic tools for signal-to-noise interpretation could significantly shift how the baseline measures of health are defined and managed. Citizen science is re-innovating the model for conducting science at every level.

In the traditional research model (Figure 1), there is a principal investigator at an institution, conducting research on subjects, under the purview of an Institutional Review Board, supported by grant funding and publishing results in journals.

Figure 1. Traditional Science Research Model



The citizen science model (Figure 2) is different as there is no distinction between investigator and subject, everyone is an investigator and participant; therefore the analog to the IRB is different, perhaps there are citizen ethicists, or a list of FAQs. Funding could come from patient advocacy groups, innovative research foundations, social venture capital, and crowd-sourcing; and research results could be self-published on the web.

Figure 2. Citizen Science Research Model
(source: DIYgenomics - an open platform for citizen science research)

Sunday, September 13, 2009

VC guide to anti-aging biotechnology investing

Several promising startup companies focused on the nascent but obviously significant and growing anti-aging biotechnology space were present or discussed with interest at the recent SENS4 (Strategies for Engineered Negligible Senescence) conference in Cambridge, U.K., September 3rd – 7th, 2009 (program) (full conference report).

  1. Epeius Biotechnologies, San Marino, CA, USA: Rexin-G, a tumor-targeted injectable gene delivery system
  2. FoldRx, Cambridge, MA, USA: small molecule therapeutics to treat protein misfolding diseases, and bind and clear undesired molecules
  3. Gencia Corporation, Charlottesville, VA, USA: mitochondrial DNA rejuvenation using the rhTFAM (recombinant-human mitochondrial transcription factor A) protein
  4. Genscient, Fountain Valley, CA, USA: novel chronic disease therapeutics by combining genomics and selective screening (a large Alzheimer’s Disease genetic study is in progress with Kronos and TGen)
  5. Knome, Cambridge, MA, USA: whole human genome sequencing (consumer offering)
  6. Neotropix, Malvern, PA, USA: oncolytic viruses for the treatment of solid tumors
  7. Pentraxin Therapeutics Ltd, London, UK: small molecule drug CPHPC specifically targeting SAP (serum form of amyloid P) and removing it from the blood and brains of patients with Alzheimer’s Disease
  8. Repeat Diagnostics, Vancouver, BC, Canada: telomere length measurement for total lymphocyte and granulocyte populations (consumer offering)
  9. Retrotope, Los Altos Hills, CA, USA: using isotope effect to slow down damage pathways and control metabolic processes associated with oxidative stress
  10. StemCor Systems, Inc., Menlo Park, CA, USA: bone marrow harvesting system
  11. T.A. Sciences, New York, NY, USA: telomerase activation via the single molecule TA-65, licensed from Geron Corporation (consumer offering)
  12. TriStem Corporation, London, UK: retrodifferentiation technology to create stem cells from mature adult cells